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Abstract: - Diabetes is a chronic metabolic disease defined by high blood glucose levels (hyperglycemia), which is still a public 
health concern in the Philippines. The COVID-19 virus, caused by the SARS-COV-2 which was first reported in China has rapidly 
spread in almost all countries around the world, becoming a major global health issue. Patients with underlying medical conditions 
such as diabetes, are mostly likely to develop the severe form of COVID-19. The COVID-19 outbreak caused people to feel fear and 
worry, therefore, this research study focused on the challenges faced by patients in undergoing diabetes care and management amidst 
the COVID-19 pandemic. The research study was conducted through an online survey questionnaire that was administered to three 
hundred eighty (380) diabetic patients aged 18-59 years old, living in NCR during the COVID-19 pandemic. The patients’ status of 
diabetes care and management during the COVID-19 pandemic, challenges faced by these patients on their diabetes care and 
management during the pandemic, and the relationship between the patients’ profile and challenges faced, and their status on diabetes 
care and management were considered as variables. All data gathered were analyzed through Microsoft Excel using frequency and 
percentage. The results showed that there are more female diabetic patients than male. Most of the patients were reported to be 
employed and working from home. Low gross monthly income was reported among the patients as a consequence of the COVID-
19 pandemic. Unstable blood glucose readings and ineffective status of diabetes care and management were reported by most of the 
patients. Fear of contamination, supply issues, and not being able to leave the house because of high risk were the top three (3) 
challenges faced by the patients. Based on the findings, the profile and challenges faced by the patients have a significant effect on 
the patients’ status on diabetes care and management. In conclusion, the patients faced challenges accessing diabetes care and 
management during the COVID-19 pandemic which led to poor or ineffective diabetes management. Expanding the study to other 
regions of the country is recommended since this study is only focused in NCR. It is also recommended that the government focuses 
on the innovation, virtualization, and digitalization in healthcare to address gaps such as access of patients to health services. 
Moreover, it is suggested that the incidence of diabetes be reduced through interventions that promote people’s health and quality of 
life.  
Key Words: — Diabetes, Diabetes care and management, COVID-19 pandemic, Profile, Status, Challenges.
                                            I.   INTRODUCTION 
COVID-19 is a known viral disease caused by SARS-
CoV-2 virus and is widespread in several continents, and  
 
continues to affect lives all over the world. All individuals are 
at risk, particularly those with underlying chronic conditions 
like diabetes, making them more susceptible to developing 
severe complications from COVID-19. In the Philippines, 
diabetes continues to be a threat to the society’s wellbeing and 
health care. As claimed by the Department of Health (2017), 
diabetes is the sixth leading cause of death among Filipinos in 
2013. Over six million Filipinos are diagnosed with the disease. 
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Diabetic patients are part of the vulnerable population in the 
rise of the pandemic. This study focused on the challenges the 
patients face in diabetes care and management amidst the 
ongoing pandemic.  
 
In 2019, 7.1% of adults aged 20-79 had diabetes, which is a 
chronic metabolic disease characterized by hyperglycemia 
(Arcellana & Jimeno, 2020). The escalating incidence of the 
disease has a massive impact on third-world countries, 
especially in the Philippines. According to the International 
Diabetes Federation (2020), there are 3,993,300 diabetes cases 
in every 63,265,700 Filipino adults, having a prevalence rate of 
6.3% in adults. Particularly in NCR, there were a total of 30,212 
diabetes cases as of December 31, 2017 (NCDPCP 
Coordinators, 2017). By 2025, it is anticipated that Asia will 
witness a tremendous increase in people with diabetes (Tan, 
2020). 
The COVID-19 outbreak forced significant parts of the 
Philippines to initiate lockdowns and follow quarantine 
protocols, with no guarantee that things will go back to normal. 
The burden of both diseases - diabetes and COVID-19 in the 
Philippines is heavy. Diabetes, being a chronic disease, 
necessitates multimodal management incorporating nutritional 
therapy, pharmacologic therapy, medical therapy, close 
monitoring, then follow up (Arcellana & Jimeno, 2020). If left 
untreated or undertreated, the condition will worsen, leading to 
the accumulation of sugar in the blood. This also leads to 
complications resulting in damage to vital organs that leads to 
premature death (CDC, 2020). Visible complications include 
amputation to the lower extremities, heart disease, blindness, 
failure of kidney operations, as well as being prone to 
infections. The quarantine measures have made diabetes care 
more challenging than ever. Health practitioners can only 
handle a limited number of patients since they are busy treating 
COVID-19 patients. 
 
The coronavirus pandemic gave rise to barriers that hindered 
the proper implementation of diabetes care and management. 
Due to the emergence of this pandemic, not only are hospitals 
and clinics forced to close most of their outpatient facilities 
from face-to-face consultations, but they are also not able to 
perform most laboratory and imaging investigations just like 
before (Shin et al., 2020). Patients that require complex 
therapeutic regimens such as multiple daily injections (MDI) or 
insulin and continuous subcutaneous insulin infusion (CSII) are 
the ones who will feel the weight of such circumstances 
(Maddaloni et al., 2020). The high cost of medications, 
especially for underprivileged individuals who have difficulty 
purchasing their medicines even before this pandemic, is the 
most frequent barrier to diabetic patients. Moreover, refilling of 
prescriptions in the setting of an enhanced community 
quarantine remains a daunting task. The usage of old 
medications remains unclear, whether or not old prescriptions 
should be considered valid in pharmacies during this time of the 
pandemic (Arcellana & Jimeno, 2020). Increased risk of 
acquiring obesity is caused by stress and physical inactivity at 
home (Nouhjah & Jahanfar, 2020), as well as the daily routine 
of most people during these times have increased the 
occurrence of a sedentary lifestyle and psychological burden for 
diabetic patients (Maddaloni et al., 2020). All of these activities 
will result in a change in glucose control. 
 
Diabetic patients are especially susceptible to the harsh 
consequences of the COVID-19 pandemic. As stated by Arcella 
& Jimeno (2020), consistent management of blood sugar is 
required to prevent an immunocompromised state that leads to 
an increased risk of contracting and developing the 
complications of acquiring COVID-19. Nam et al. (2011) 
suggested that identifying barriers to diabetes management is 
required to improve the quality of diabetes care, including the 
improvement of metabolic control and diabetes self-
management. Therefore, it is crucial to know and understand 
the impact of the pandemic on people living with diabetes to 
improve the overall health conditions of the patients. 
 
This study aimed to gather data regarding the diabetes care and 
management of Filipino patients suffering from the said disease 
amidst the pandemic. With the health conditions of these 
patients compromised during these times due to their weakened 
immune system caused by the disease, as shown by the studies 
conducted about it, it is pertinent that the government must take 
timely action to remedy the situation they are in to keep them 
safe from being affected by the virus while managing the care 
of their disease.  
 
1.1 Objectives of the Study 
 
The general objective of the study was to determine the 
challenges faced by patients undergoing diabetes care and 
management during the COVID-19 pandemic in the 
Philippines. 
 
The specific objectives of the study were the following: 
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 To determine the socio-demographic profile of 
diabetic patients in the Philippines. 
 To determine the self-assessed status of diabetes care 
and management during the COVID-19 pandemic. 
 To determine the challenges faced by these patients on 
diabetes care and management during the COVID-19 
pandemic. 
 To determine if the patients’ status on diabetes care 
and management is affected by their profile and 
challenges they faced during the COVID-19 
pandemic. 
 
1.2 Problem Statement 
 
The study generally aimed to determine the challenges faced by 
patients who have diabetes in obtaining quality diabetes care 
and management during the COVID-19 pandemic. 
 
Specifically, the study sought to answer the following 
questions: 
 What is the socio-demographic profile of diabetic 
patients in the Philippines  
 How would the patients assess their status of diabetes 
care and management during the COVID-19 
pandemic? 
 What are the challenges faced by these patients on 
diabetes care and management during the COVID-19 
pandemic? 
 Is the patients’ status on diabetes care and 
management affected by their profile and challenges 
they faced during the COVID-19 pandemic? 
 
1.3 Hypothesis of the Study 
 
H0: The patients’ status of diabetes care and management was 
not affected by their profile and challenges they faced during 
the COVID-19 pandemic 
H1: The patients’ status of diabetes care and management was 
affected by their profile and challenges they faced during the 
COVID-19 pandemic 
 
1.4 Research Impediments 
 
The main purpose of this study was to identify the challenges 
encountered by patients in the care and management of diabetes 
amid the COVID-19 pandemic for effective management of the 
disease. This study was limited to the Philippine setting, 
particularly the National Capital Region (NCR), and did not 
include the challenges in diabetes care and management of 
other countries. The respondents of the study were limited to 
380 diabetic patients, aged 18-59 years old, who are residents 
of NCR during the COVID-19 pandemic. This sample size was 
based on the 2017 data from NCDPCP, which was the latest 
data available on the internet as of 2020. This study was 
descriptive correlational research, and data gathering was 
limited to conducting surveys through online platforms because 
of the restrictions imposed by the IATF as part of the protocols 
during the COVID-19 pandemic.  
 
1.5 Significance of the Study 
 
The findings of the study would be beneficial to the following: 
 
Diabetic Patients. This study would be an opportunity for them 
to inform the government and healthcare providers about their 
current situation, especially the challenges they are facing in 
managing their disease during the COVID-19 pandemic. 
Furthermore, this study could establish recommendations that 
will air the concerns of the patients. 
 
Health Care Providers. This study would serve as a way for 
these healthcare providers to analyze, examine, and evaluate the 
challenges for diabetes care and management in the Philippines. 
In addition, possible recommendations and actions for 
improvement may be established by these health care providers 
to alleviate and deal with the problem. 
 
The Government. This study would help the government 
discover the current situation of diabetic patients in the 
Philippines and the challenges they face in managing the 
disease during the COVID-19 pandemic. Moreover, this study 
could recommend possible actions the government could 
establish to deal with these challenges and help these diabetic 
patients. 
 
Medical Technology Students. This study would give the 
researchers further knowledge about diabetes care and 
management in the Philippines during the COVID-19 
pandemic. 
 
Future Researchers. This study could serve as a source of 
information and data that future studies may use. This may also 
be an inspiration or a basis for many complex research studies 
in the medical field. 
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1.6 Definition of Terms 
 
For clarity and a better understanding of the study, the 
following terms were defined based on the research content. 
 
COVID-19 pandemic. This global health crisis, caused by the 
new coronavirus, was declared on 11 March 2020 by the World 
Health Organization (WHO). 
 
Diabetes. A chronic condition in which the body cannot 
properly convert the food into energy. 
 
Diabetes care and management. This is a system of coordinated 
healthcare interventions and communications for diabetic 
patients to encourage them and guide them in self-managing 
their illness and help them improve their conditions and overall 
quality of life. 
 
Diabetes maintenance drugs. These are the prescribed 
medications for diabetic patients that are taken on a regular, 
recurring basis. 
 
Diabetic nutrition. This refers to the diet used by people with 
diabetes to minimize symptoms and dangerous complications 
of long-term elevations in their blood sugar. 
 
Diabetic patient. This is an individual suffering from high 
blood sugar levels. 
 
Hyperglycemia. High blood sugar. 
 
Hypoglycemia. Low blood sugar. 
 
Impediments. These are the barriers to acquiring proper care 
and management on the treatment of diabetes. 
 
Medical needs. These are the health care services provided to a 
patient by a physician to help evaluate, diagnose, or treat 
diabetes. 
 
Pharmacologic therapy. This refers to the treatment of diabetes 
through the administration of certain drugs. 
 
Quarantine measures. These are the limitations of face-to-face 
contact and mobility restrictions that are necessary to prevent 
the spread of COVID-19 disease. 
Significant changes. The measurement of the effect of the 
treatment being done on diabetic patients. This is to measure 
whether the treatment is taking effect in helping them get better 
or not. 
 
Vulnerable populations. These are the groups and communities 
with a higher risk of contracting COVID-19 infection due to the 
manifestation of conditions that affect their immune system. 
                   II.    THE REVIEW OF RELATED LITERATURE 
Diabetes, along with other non-communicable 
diseases, make up six of the top ten leading causes of mortality 
in the Philippines as stated by the DOH. According to the 
Philippine Health Statistics (2016), diabetes is the 6th leading 
cause of death, which makes up 5.7% of total deaths for both 
sexes. The paper also shows that the disease is the 8th leading 
cause of mortality for males (4.9%) and the 5th leading cause 
of mortality for females (6.8%). According to a census from the 
International Diabetes Federation (2020), the prevalence of 
diabetes in the adult population of the Philippines for the second 
quarter of 2020 reaches 6.3 percent. Diabetes remains a 
significant public health concern as the prevalence of the 
disease increases year by year since 1980. The most common 
type of diabetes in the Philippines is NIDDM or Type II 
diabetes, which makes up for most of the cases of diabetes. It 
has a 9-year incidence of 16.3% and a prevalence of 28.0% 
from 1998 to 2007 (Soria et al., 2009). Gestational diabetes is 
problematic as it affects both the mother and the offspring. This 
type of diabetes is substantially prevalent in the Philippines, 
which affects 14% of pregnancies (AFES Study Group on 
Diabetes in Pregnancy, 1996). There are no nationwide 
incidence or prevalence studies about Type 1 diabetes in the 
Philippines. According to a publication by UNITE for Diabetes 
Philippines (2008), there exists a survey by Castillo-Cruz that 
shows a very low prevalence of type 1 diabetes with only 7 
cases among children aged 0-14 in a small municipality in 
Bulacan from 1989 to 1998. 
 
According to the third policy note of the UP COVID-19 
Pandemic Response Team (2020), it revealed that the physician 
density in the Philippines as of April 2020 is at best 10 per 
10000 population in the National Capital Region while the 
lowest ratio is seen in the Bangsamoro Autonomous Region of 
Muslim Mindanao (BARMM) with only 0.8 physicians per 
10000. This reveals that there is a remarkable inequality in 
physician distribution in the country. The data shows that 
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access to physicians, such as endocrinologists, is inferior in 
underdeveloped regions. Diabetic Care in the Philippines is 
reported to have a balanced performance across all areas except 
in policies and funding (IDF, 2014). According to the data from 
the Family Income and Expenditure Surveys (2018), half of the 
families categorized under the lower income bracket spend 
most of their medical expenditures on the purchase of medicinal 
drugs. Most of these households pay these fees out of pocket, 
which eventually takes their toll on the financial status of these 
families. A health insurance would help cover these fees and 
medical costs. PhilHealth is a government insurance 
corporation attached to the DOH that aims to provide universal 
health care coverage for Filipinos (Philhealth, n.d.). Through 
PhilHealth Circular No. 017s 2014, PhilHealth reimburses a 
substantial amount for treatment and coverage of maintenance 
drugs for non-communicable diseases, especially diabetes. 
However, limited medications for diabetes are covered by the 
insurance. Other measures done by the government to curb the 
rising incidence of diabetes and alleviate the disease burden 
include programs by the DOH such as the Diabetes Awareness 
campaign, which is held every fourth week of July, aiming to 
educate people about diabetes. 
 
Handling the medical care of patients in the Philippines is 
difficult, brought about by a doctor-patient ratio of 1:33,000, 
(Sandoval, 2016) whereas the ideal ratio imposed by the World 
Health Organization (WHO) is one doctor for every 10,000 
persons. Because of the pandemic, diabetes management 
became more challenging since most healthcare professionals 
are deployed to battle against the crippling COVID-19 
pandemic. The people who have diabetes are both the direct and 
collateral damage of this pandemic. Diabetes is a chronic 
disease, and it requires multimodal management integrating 
medical nutritional and pharmacologic therapy, exercise, close 
monitoring, and follow-up (Arcellana, 2020). The mobility of 
the healthcare system is limited due to the protocols and safety 
measures deployed to minimize the spread of COVID-19 in the 
country. The risk of nosocomial diseases for 
immunocompromised patients, such as diabetic patients, is also 
a problem when going to a hospital for a check-up. Insulin is a 
necessity in managing diabetes due to the pancreas no longer 
secreting insulin. Moreover, insulin is a prescribed drug, 
meaning a patient needs a physician’s prescription to purchase 
it in pharmacies. Disparities in health care delivery and drug 
access make this situation worse (Nouhjah, 2020.) 
                              III.    THEORETICAL STUDY 
Chronic illnesses demand extensive care and 
management in maintaining health and improving the overall 
outcome of the patient. A middle-range theory by Riegel et al. 
(2012) of Self-Care of Chronic Illness indicates that self-care is 
considered important in the management of chronic illness. The 
theoretical basis took into account the difficulties that patients 
had in taking care of themselves when their options were to 
fulfill the needs determined by their chronic illness (Riegel et 
al., 2012). According to the theory, most patients seek care 
because they want alleviation from symptoms caused by their 
illness or its treatment, especially within the structured health 
care system. It also highlighted the importance of engagement 
and cooperation between healthcare providers and patients in 
encouraging patients to connect with and integrate self-care into 
their lifestyle. This philosophy has embraced the role of health 
care practitioners in supporting self-care and focuses 
specifically on how patients act and cope with their chronic 
disease. 
Self-care maintenance, self-care monitoring, and self-care 
management were described as three major principles in the 
theory. Patients with chronic illnesses engage in self-care 
maintenance to maintain their physical and mental well-being. 
Self-care monitoring is the practice of observing one's own 
indications and symptoms for changes. Finally, self-care 
management is the process of responding to indications and 
symptoms as they arise. When applied to chronic illness, these 
three key concepts must follow the recommendations of 
healthcare providers (Riegel et al., 2012). Moreover, it is 
believed that adherence to therapies and systematic and routine 
monitoring is essential in attaining the best outcomes.  
As practicing and promoting self-care is an extremely 
challenging process for both patients and clinicians, this theory 
describes the factors which influence self-care, including 
experience, motivation, habits, culture, skill, confidence, 
functional and cognition, and support from others, and access 
to care. This study is mainly concerned with the access to care 
of individuals with chronic illness, specifically diabetic patients 
during the COVID-19 pandemic. The theory recognized the 
significance of using the health-care system to get care and its 
impact on the patient's overall health. However, many of these 
persons with chronic illnesses do not have access to healthcare 
providers within the organized health care system for a variety 
of reasons, which leads to poor health outcomes. 
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                                 IV.   RESEARCH DESIGN 
4.1 Subjects and Study Site 
This study was conducted in the National Capital 
Region (NCR). According to the Department of Health (2020), 
the National Capital Region is the one with the most number of 
COVID-19 cases among the regions in the Philippines. Hence, 
it is placed by the Inter-Agency Task Force under stricter 
restrictions that affect the diabetes care and management of the 
patients. The target population for this study was three hundred 
eighty (380) diabetic patients living in NCR during the 
pandemic. The researchers limited the age group to diabetic 
patients aged 18-59 years only, for the reason that individuals 
under the age of 18 need parental consent, and individuals 
above the age of 59 are considered senior citizens. Both groups 
were excluded from this study because they are part of the 
“vulnerable” population. Purposive sampling was used for 
selecting the respondents of the study. This method belongs to 
nonprobability sampling techniques, where the respondents are 
selected based on their knowledge and relationship about the 
research topic (Freedman et al., 2007).  
In this study, the respondents selected were 
individuals, aged 18-59 from the National Capital Region, 
confirmed to be diagnosed with diabetes by examining the 
proof of diagnosis submitted in the pre-survey section of the 
questionnaire. The respondents participated in the survey 
through the use of Google Forms. The minimum recommended 
sample size was 380 respondents. Sample size (n) was 
calculated using the following formula: x = Z(c/100)²r(100-r) 
and n = Nx/((N-1)E²+x), where Z(c/100) is the critical value of 
the confidence level (95%), r is the fraction of response (50%), 
E is the margin of error (5%), and N is the population size of 
diabetic patients in NCR as of December 31, 2017. 
4.2 Data Measure/Instrumentation 
This study utilized a questionnaire to quantify the data 
gathered. The questionnaire used in this study was adapted from 
the International Diabetes Federation (IDF) European Region 
and the researchers had sought their approval in adapting the 
questionnaire for the purpose of this study. The researchers 
received an email from the IDF European Region that granted 
them permission to use and adapt the questionnaire. The 
researchers, however, modified the said questionnaire based on 
what is needed in the study. 
4.3 Data Gathering Procedure 
Quantitative data were gathered using an online 
survey questionnaire due to the limitations imposed by 
COVID-19. The online standardized survey questionnaire was 
adapted from IDF which also focuses on the challenges of 
diabetes care and management during COVID-19. The survey 
obtained information on the effects of patients’ profile and the 
challenges they faced on their status on diabetes care and 
management during the COVID-19 pandemic. 
The initial copy of the survey was submitted to the Ethics Board 
Committee for approval. After approval, the questionnaire 
underwent pilot testing for a test of comprehensibility. After the 
validation of the questionnaire, final revisions were applied. 
After finalization, the researchers selected the respondents 
using purposive sampling that fits the inclusion criteria, 
including male or female, ages 18-59 diabetic patients coming 
from the National Capital Region (NCR). A consent form was 
given to the respondents to inform them about the purpose of 
the study, the procedures involved, and the risks and benefits of 
participating in the study. A pre-survey questionnaire was first 
given to the respondents before proceeding to the actual survey 
questionnaire. This was to ascertain that the respondent meets 
the qualifications for the purpose of this study. The researchers 
asked for proof of diagnosis which may include drug 
prescription, medical certificate, or blood analysis results from 
a reputable diagnostic center, or from a diabetologist or an 
internist. The consent form, together with the pre-survey and a 
survey questionnaire were distributed through online platforms 
targeting 380 respondents. The URL link of the questionnaire 
was shared through different social media sites such as 
Facebook, Instagram, or Twitter. It was also shared with 
different diabetic groups found on social media sites. The link 
was also sent to the acquaintances of the researchers for more 
effective dissemination. The answers were gathered from the 
questionnaires, which were quantified by tallying each 
response. Together with the help of a statistician, the 
researchers generated the results gathered from the 
questionnaire. After the generation of statistical results, the 
researchers analyzed the results, and conclusions were made. 
The results were kept confidential in order to protect the 
identity of the respondents.  
The informed consent form was given to the respondents 
together with the questionnaire through Google Forms to make 
sure that the respondents were fully informed regarding the 
purpose of the study. The respondents were allowed to refuse 
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to participate in the study without penalty. Participation was 
entirely voluntary and if he or she decided to participate, 
withdrawal from the study at any point was possible. The 
consent form also asked the respondent to share personally 
identifiable information for verification purposes. Guaranteed 
that all personal information was used exclusively for research 
purposes and that the identity of the respondents remained 
confidential. The questionnaire provided confirmation from the 
respondents on their agreement and consent for participation in 
this research study.  
The duration of the study was approximately ten months. It took 
approximately ten to twenty minutes for the respondents to 
accomplish the online survey questionnaire.  
4.4 Ethical Consideration 
An informed consent form, together with the survey 
questionnaire, was given to the willing respondents online. The 
respondents were free to withdraw anytime they did not wish to 
participate in the survey anymore. They were asked beforehand 
if they would allow the researchers to release their answers for 
research purposes. They were aware of the purpose of the study 
and that no name or any identifying information will be 
accessible to anyone else but the researchers. They remained 
anonymous for confidentiality reasons. Moreover, to ensure 
that the study did not, in any form, cause harm and violate any 
rights and privacy of the respondents, this thesis proposal was 
submitted to the Faculty of Pharmacy – Ethics Review 
Committee for evaluation and to secure ethics clearance. 
4.5 Data Analysis 
 In order to obtain an understanding of the respondents, 
descriptive statistics was used. Descriptive statistics are 
techniques that are designed to provide an idea of the 
distribution of your variables (George & Mallery, 2016). 
Frequencies and percentages were utilized to better organize 
and summarize categorical data to explain these variables; 
status of diabetes care and management during the pandemic, 
challenges faced by diabetic patients on their diabetes care and 
management during the pandemic.  
To further look into the relationship between the status of 
diabetes care and management during the pandemic of the 
patients and the challenges they faced during the pandemic, the 
researchers made use of Pearson r coefficient of correlation.  
All of the statistical tests were performed in Microsoft Excel.  
                             V.    RESULTS AND DISCUSSION 
This chapter contains the results gathered from the 
survey-questionnaire that was done and how they were treated 
and analyzed. It presents the results of the statistical analysis 
and the interpretation of findings.  The results are presented 
through the use of tables and figures.  
 
5.1 Socio-Demographic Profile 
This section presents the demographic profile of the 
patients which includes their employment status, monthly 
family income, and their sex. 






income of the 
family 
f % 
Employed - at 
usual place at 
work 























4 1.05% P76,670 to 
P131,483 
4 1.05% 
Unemployed 11 2.89% P131,484 to 
P219,140 
4 1.05% 
Student 7 1.84% Prefer not to 
Answer 
71 18.86% 
Retired 23 6.05% Total 380 100% 
Others 2 0.53%    
Total 380 100%  
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Sex f % 
Male 151 39.74% 
Female 229 60.26% 
Total 380 100% 
 
The table shows 60.26% of the patients are females while the 
remaining 39.74% are males. It can be inferred that females are 
more likely to have diabetes than men as per the publication 
made by the Philippine Health Statistics (2016) where diabetes 
is the 5th leading cause of mortality for the females (6.8%) 
while 8th leading cause for men (4.9%). 
The patients are mostly employed while working at home 
(50.26%). Moreover, the patients’ monthly gross income is 
primarily P10, 958 to P21, 914 (30.79%) and P21,915 to 
P43,828 (34.47%). The data shows that the patients are mostly 
in the Low-income but not poor and lower middle income 
bracket as identified by the Philippine Institute for 
Development Studies (PIDF, 2018). 
5.2 Status of Diabetic Patients during COVID-19 
 
This section contains information on how well the 
patients were able to manage their diabetes, as well as other 
variables that may serve as an indicator of their status such as 
blood glucose readings and glycemic control. It also contains 
the eating habits and food planning method employed by the 
diabetic patients during the COVID-19 pandemic and how able 
they were to follow their intricate diet despite the possible 
challenges on diabetes food supplies. It contains information 
about the diabetes treatment taken by the patients, as well as 
their ability to follow their diabetes regimen. Lastly, it discusses 
the ability of the patients to receive any form of diabetes care 
and consultations during the pandemic 
 
5.2.1 Management of Blood Glucose Levels: 
During the COVID-19 pandemic, 46.58% of the patients were 
able to measure their blood glucose levels the same as before 
the pandemic started. However, there is a significant group of 
patients (45.53%) who had a decrease in the frequency of 
measuring their glucose levels. This is likely due to the 
difficulty in obtaining POCT or measuring devices for blood 
glucose such as the glucometer which is seen in Table 16 in 
section 4.3. 









25 6.58% More stable than 
usual 
27 7.11% 
Same as usual 177 46.58% About the same 149 39.21% 
Less than usual 173 45.53% More variable 
than usual 
202 53.16% 
Not applicable 5 1.32% Not applicable 2 0.53% 
Total 380 100% Total 380 100% 
 
When it comes to the state of their blood glucose levels during 
the pandemic, about 53% of the patients reported that their 
levels have been more variable than usual, while a significant 
population of 39.21% of the total patients reported that their 
levels are the same as before the pandemic. The data shows that 
the majority of the patients were unable to effectively manage 
their blood glucose levels during the pandemic. Upon further 
analysis, 68.32% of the patients who reported having more 
variable glucose readings apparently measure their glucose 
levels less than usual. Variability in the readings in spite of 
lesser frequency of measurement may be explained by the 
patient’s inability to continuously monitor and control their 
glucose levels, thus resulting in a spike in measurements. 
 
5.2.2 Glycemic Control: 
About three-fourths of the patients had an episode of 
hypoglycemia. A majority of the total patients, which 
constitutes 36.32%, reported that there were no differences 
between the number of hypoglycemic events prior and during 
the pandemic, with some 35.53% of the patients reported that 
they experienced these hypoglycemic events less than before. 
The results show that a significant number of the patients were 
able to control their blood glucose levels in a way that lessens 
the frequency of hypoglycemic events. The lower frequencies 
of hypoglycemia may be due to the prevalence of Type II 
diabetes in the Philippines. Hypoglycemia is much more 
common in Type I diabetes but it can also occur in Type II 
diabetes. 
Table.3. Blood glucose status of the patients 
Hypoglycemic 
episodes 





17 4.47% More than usual 216 56.85% 
Same as usual 138 36.32% Same as usual 120 31.58% 
Less than usual 135 35.53% Less than usual 31 8.16% 
None 90 23.68% None 13 3.42% 
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Total 380 100% Total 380 100% 
 
There were 56.85% of the patients who reported that their 
hyperglycemic events had increased during the pandemic, 
while some 31.58% reported that there were no differences in 
the number of hyperglycemic events prior and during the 
pandemic. This indicates that 56.85% of the patients were 
unable to manage and control their blood glucose levels within 
healthy ranges. This increase in the number of hyperglycemic 
events indicates the ineffectiveness of the patients to manage 
their diabetes due to the indirect challenges caused by the 
COVID-19 pandemic. 
 
5.2.3 Diabetes Management: 
The COVID-19 pandemic led the national government to 
impose an extensive lockdown measure that restricts 
movements of people. This restriction led to shortages in 
resources which includes diabetic medications and devices 
which makes it difficult for diabetic patients, who are 
considered as “collateral victims”, to access proper diabetic 
care during the pandemic and thus negatively impacts their 
diabetes management (Arcellana & Jimeno, 2020). About 
43.16% of the patients reported an average performance in 
managing their diabetes, while a significant 41.84% of them 
reported not managing their diabetes very effectively. The set 
restrictions and lockdowns is the likely cause of the negative 
performance of the patients with regards to diabetes 
management 
Table.4. Patient’s assessment on their ability to manage diabetes 
Ability to manage diabetes f % 
Very effectively 9 2.37% 
Effectively 46 12.11% 
Average  164 43.16% 
Not very effectively 159 41.84% 
Not effectively at all 2 0.53% 
Total 380 100% 
 
5.2.4 Weight Changes and Physical activity: 
Some 25.26% of the patients had their body weight maintained 
while 42.37% had lost weight, and 32.37% had regained body 
weight.  
Moreover, 69.74% of the patients did not deliberately lose 
weight. It can be inferred that the weight change is 
unintentional; this points to less physical activity (66.05%) and 
mismanagement (Table 3) of the patients’ diabetes which are 
the main factors for the weight change. 
 
Table.5. Variations in weight and physical activity 
Gained or 
lost weight 
f %  Deliberate 
weight change 
f % 
I have lost 
weight 
161 42.37% Yes 45 11.84% 
My weight has 
remained 
stable 
96 25.26% No 265 69.74% 
I have gained 
weight 
123 32.37% Not applicable 70 18.42% 

















Total 380 100% 
 
5.2.5 Patient’s appetite during the pandemic: 
The table lays out the patients’ appetite during the pandemic. 
Table 6 states that 82.11% of the patients take 1-3 meals a day 
while 30.79% of the patients have increased appetite and 
53.16% had their usual appetite. This points to mismanagement 
of diabetes because even with normal appetite, it is not enough 
to manage their diabetes. Additionally, this is due to less 
physical activity (Table 5) during the COVID-19 pandemic. 
Table.6. Satiety of the patients 
Frequency of 
meals 
f %  Appetite during 
the pandemic 
f % 
1-3 Meals 312 82.11% Increase 117 30.79% 
4-6 Meals 66 17.37% Normal 202 53.16% 
More than 6 
meals 
2 0.53% Decreased 61 16.05% 
Total 380 100% Total 380 100% 
 
5.2.6 Diet: 
Based on the findings at Table 7, 71.32% of the patients are 
resorting to healthy eating as their food planning method. 
Patients who have been imposed diet restrictions followed a 
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low calorie diet for 35.00% of the population and 20.53% 
followed a low cholesterol diet. 
Table.7. Patient’s food lifestyle choices 
Food 
planning 
method to use 





45 11.84% Yes 313 82.37% 
Carbohydrate 
Counting 
30 7.89% High fiber 23 6.05% 
Healthy Eating 271 71.32% Low Calorie 133 35.00% 
Using the 
Food Pyramid 
9 2.37% Low Cholesterol 78 20.53% 
Other 4 1.05% Low fat 14 3.68% 
None 20 5.26 Low Protein 5 1.32% 
Not applicable 1 0.26% Low Salt/Sodium 41 10.79% 
Total 380 100% Not applicable 12 3.16% 
 Other 7 1.84% 
No 67 17.63% 
Total 380 100% 
 
From this table, it is evident that the patients were not able to 
properly follow their diet restrictions and food planning 
methods. Based on the data below, 41.32% of the patients have 
a difficult time and 22.63% find it ‘very difficult’ to follow their 
diet restrictions. Similar to that, it is hard for 46.58% of patients 
to stick to their dietary planning methods. 
 










Not at all 
difficult 
12 3.16% Not at all difficult 9 2.37% 
Not very 
difficult 
43 11.32% Not very difficult 43 11.32% 
Not easy not 
difficult 
72 18.95% Not easy not 
difficult 
57 15.00% 
Difficult 157 41.32% Difficult 177 46.58% 
Very difficult 86 22.63% Very difficult 81 21.32% 
Not applicable 10 2.63% Not applicable 13 3.42% 
Total 380 100% Total 380 100% 
 
5.2.7 Food intake frequency of the Patients: 
Based on this graph, the patients were not able to follow their 
 
Fig.1. Food intake frequency of the Patients 
food planning method since most of the patients answered 
‘Sometimes’ for the following: Sweets (85.79%), Beverages 
with sugar (81.32%), and Alcoholic beverages (68.95%). 
 
5.2.8 Diabetes Medication of the Patients: 
Table.9. Diabetes Treatment Taken by the Patients 
Ability to Follow Diabetes 
Regimen  
f % 
Less able than usual 184 48.42% 
Same as usual 168 44.21% 
More able than usual 17 4.47% 
Not applicable 11 2.89% 
Total 380 100% 
 
This table displays the medication taken by the patients to treat 
their diabetes. The majority of the patients (57.11%) treat their 
diabetes through control of diet and oral medication, while diet-
controlled treatment is used by 28.42% of the total patients. It 
also shows that 6.58% of the patients use oral medication only 
to treat their diabetes while 2.89% of the patients combine it 
with control of diet and insulin. A combination of oral 
medication and insulin is used by 2.11% of the patients, and a 
total of 1.32% treat their diabetes through control of diet and 
insulin. Lastly, 1.05% of the patients only use insulin as their 
diabetes treatments.  
The table also shows that 4.74% of the patients use the syringe 
injections to take their insulin, while 2.37% use insulin pen 
device(s), and 0.26% of the patients use an insulin pump.  
Majority of the patients (92.37%) answered not applicable since 
they do not use insulin as their diabetic medication.  
As stated in chapter 2, it is important for diabetic patients to 
have good glycemic control to prevent uncontrolled levels of 
blood sugar. Oral medications, insulin, and diet-controlled are 
utilized by the patients as their treatment. Patients with Type 1 
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diabetes mellitus are highly dependent on exogenous insulin 
since they do not produce insulin. The lower prevalence of 
individuals with Type 1 diabetes mellitus as compared to those 
with type 2 diabetes mellitus explains the low frequency of 
those who use insulin as a treatment.  
 
5.2.9 Patients’ Ability to Follow their Diabetes Regimen: 
Table.10. The Ability of the Patients to Follow Their Diabetes 
Regimen 
Ability to Follow Diabetes 
Regimen  
f % 
Less able than usual 184 48.42% 
Same as usual 168 44.21% 
More able than usual 17 4.47% 
Not applicable 11 2.89% 
Total 380 100% 
 
This table displays the ability of diabetes patients to follow their 
diabetes regimen which includes blood glucose testing and 
taking their medication as prescribed during the COVID-19 
pandemic. It shows that 48.24% of the patients were less able 
to follow their diabetes regimen as usual, while 44.21% of the 
patients reported that they were able to follow their diabetes 
regimen the same as prior to the pandemic. The data also shows 
that 4.47% of the total patients were more able to follow their 
diabetes regimen than usual. This shows that the majority of the 
patients were less able to follow their regimen, hence, they are 
not able to manage their diabetes well.   
 
Table.11. Patients’ Stockpiling of Diabetes Medications and 
Equipment  
Stockpiling Diabetes 
Medications and Equipment 
More than Usual 
f % 
Yes 88 23.16% 
No 289 76.05% 
Not applicable 3 0.79% 
Total 380 100% 
 
This table presents the patients who stockpiled diabetes 
medications and equipment during the COVID-19 pandemic. 
Out of 380 patients, 289 (76.05%) patients did not stockpile 
medications and equipment and only 88 patients (23.16%) 
stockpiled diabetic medications and equipment. Considering 
that diabetic patients are high-risk to contracting COVID-19, 
they are unable to leave the house to go buy their medications, 
and equipment. There are also issues in the availability of the 
medications and equipment that pose a barrier for the patients.  
 
5.2.10 Advice from Health professionals: 








No 168 44.21% No 152 40.00% 
Not 
applicable 
6 1.58% Not applicable 97 25.53% 
Yes 206 54.21% Yes 131 34.47% 
Total 380 100% Total 380 100% 
 
This table shows 54.21% of the patients received advice from 
healthcare professionals to manage their condition during the 
COVID-19 outbreak. However, 44.21% of the patients were 
reported to have not received advice from healthcare 
professionals. This indicates that there is still a significant 
number of patients who were unable to receive advice from 
healthcare professionals which may lead to them being unable 
to manage their blood glucose levels. Due to the lack of advice 
from healthcare professionals, the patients may rely on 
information they just read on the Internet, preexisting 
knowledge, and even superstitious beliefs which may lead to 
mismanagement of diabetes.  
This table also displays that the majority of the patients (40%) 
were reported to have not been contacted proactively by their 
physicians while 34.47% of the patients reported that their 
physicians proactively reached out. This is likely due to the 
doctor-to-patient ratio of 1:33,000 in the Philippines which 
makes reaching out to patients challenging especially during the 
COVID-19 pandemic (Sandoval, 2016). As stated in Chapter 2, 
the World Health Organization (WHO) recommends one doctor 
for every 10,000 patients which makes the doctor-to-patient 
ratio of the Philippines significantly lower and this may 
influence the quality of health services in the country. 
 5.2.11 Check-ups and consultations: 





No 109 28.68% 
Not applicable 14 3.68% 
Yes, face to face 234 61.58% 
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Yes, virtually (telephone, 
online) 
23 6.05% 
Total 380 100% 
 
This table shows that the majority of the patients attended face 
to face diabetes-related consultations during COVID-19, 
comprising 61.58% of the population. However, a significant 
group of patients, constituting 28.68% of the population 
reported to have not attended any diabetes-related consultations 
during COVID-19. This is probably due to the fear of 
contracting the virus causing COVID-19, hence, 6.05% of the 
patients opt for virtual diabetes-related consultations. In 
addition, 3.68% of the patients said that diabetes-related 
consultations during COVID-19 were not applicable to them.  
 






























229 60.26% I attended my 
diabetes 
consultations via 
an online platform 
9 2.37% 






attended a few 




2 0.53% Others  2 0.53% 





   
Consultation
s 









Helpful 14 34.15% 
Very helpful 14 34.15% 
Total 41 100% 
 
This table shows that 60.26% of the patients did not attend any 
virtual diabetes consultation during COVID-19, while 25.26% 
said that it is not applicable to them and 9.21% preferred 
attending face-to-face consultations even though remote 
consultations were available. However, a small proportion of 
the population still opt for virtual diabetes consultation wherein 
4.74% of the patients attended few appointments virtually and 
0.53% of the patients attended them regularly. These virtual 
diabetes consultations were conducted via phone, online 
platforms, or email. It was reported that 93.95% of the patients 
were “Not applicable” because they did not attend virtual 
diabetes consultations, 2.63% attended by phone, 2.37% 
attended via online platforms, and 0.53% attended via email. 
This table also shows the patients' rating on virtual diabetic 
consultations, applicable only to those who have attended. Out 
of the three hundred eighty (380) patients, only 10.79% of the 
population attended virtual diabetes consultations.  
The virtual diabetes consultations were perceived to be helpful 
by 34.15%, very helpful by 34.15% and slightly helpful by 
26.83%. However, 2.44% of the patients did not find them very 
helpful and 2.44% did not find them helpful at all. Since the 
majority of the population perceived them as helpful and very 
helpful, virtual diabetes consultations are therefore helpful in 
diabetes management.  
Table.15. Appointed schedule of daily management of diabetes care 
and screening of diabetes complications appointed schedule of daily 







f %  Appointed 







17 4.47% Appointment 
brought forward 
14 3.68% 
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into a virtual 
one 
13 3.42% Face-to-face 
appointment 
transformed into 
a virtual one 
5 1.32% 
I did not 
attend my 
appointment 





26 6.84% No disruptions 32 8.42% 
Not 
applicable 
71 18.68% Not applicable 165 43.42% 
Total 380 100% Others 2 0.53% 
 Total 380 100% 
 
According to the data presented above, the majority of 
the patients comprising 37.89% of the population, reported that 
their appointments for daily management of diabetes care was 
rescheduled while 27.63% of the patients reported that they did 
not attend their appointments.  
With regards to the appointment for screening of 
diabetes complications, 43.42% of the patients said it is not 
applicable to them while 22.89% of the patients reported that 
they have their appointment rescheduled. Rescheduled 
appointments may be due to the restrictions that limit face to 
face contact with other people as a way to reduce the spread of 
the COVID-19 virus while people not attending their respective 
appointments may be due to the fear of contracting the COVID-
19 virus.  
5.2.12 Patient’s access to multidisciplinary care: 
 
Fig.2. Access to multidisciplinary specialists during the pandemic 
A great number of the patients were not able to access their 
multidisciplinary teams. At least three-fourths of them were not 
able to access all of the three specialists. The majority of the 
patients who were categorized to be unable to access their teams 
did not require/did not seek the help of these three. Some 
66.84% on the diabetes nurse, 67.89% on the psychologist, and 
58.42% on the dietitian were reported to be “Not applicable” or 
the patients did not opt to have a consultation with these 
specialists. 
 
5.2.13. Patient’s review on their ability to manage diabetes 
complications: 
 
Fig.3. Rating on their management of diabetes complications during 
the pandemic 
About 69.47% of the patients felt that their management of 
diabetes complications worsened to a certain degree, brought 
about by the difficulties in diabetes care during the COVID-19 
pandemic. A majority of the total patients, about 38.4%, 
reported that their management of their complications had 
worsened, while 27.37% felt that they managed their diabetes 
complications relatively well.  
 
5.2.14. Outpatient Care: 
 
Fig.4. Patient’s report on the effectivity of their outpatient care 
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About 54% of the patients reported that their outpatient care 
was effective to a certain degree. Some 36.32% of the total 
patients, which makes the majority, reported that their 
outpatient care was not very effective and quite a similar 
proportion, 33.42%, reported to have moderately effective 
outpatient care. None of the patients reported that their 
outpatient care is not at all effective. Overall, a significant 
proportion of the patients had a negative experience with their 
outpatient care. 
 
5.2.15. Guidance given for people living with diabetes: 
 
Fig.5. Guidance given by the National Government during the 
pandemic 
 
About 96% of the patients reported that they received guidance 
from the government. An overwhelming majority of the total 
patients (84.74%) reported that the most common guidance 
given to them was to stay at home. This stay at home order is 
an advice given to the general public as a way to reduce 
transmissions of the coronavirus rather than a specific advice 
given to a susceptible group. The next common advice given 
was to physically distance, which makes 12.37% of the total 
patients while 1.84% reported to receive no guidance at all.  
 
5.3. Challenges on Diabetes Care and Management 
 
This section discusses the access of the patients to diabetes 
medications and/or supplies. It discusses the findings on 
possible shortages and the barriers encountered by the patients 
in accessing their diabetes medications, supplies, and 
equipment.  This section also discusses the barriers to accessing 
diabetes care, management of diabetic complications, and 
government response. 
 
5.3.1 Availability of Medications, Supplies and Technologies: 
Table.16. the Patients Who are Worried on Possible Shortages of 
Diabetes Medications, Supplies, and Technologies  
Worry about Possible 
Shortages 
f % 
Not at all worried 18 4.74% 
Not very worried 33 8.68% 
Slightly worried 34 8.95% 
Worried 99 26.05% 
Very worried 194 51.05% 
Not applicable 2 0.53% 
Total 380 100% 
 
This table shows the patients who are worried about possible 
shortages of medications, supplies, and technologies. Majority 
of the patients (51.05%) are very worried about possible 
shortages, while 26.05% of the patients are worried. 8.95% of 
the patients are slightly worried about the possible shortages, 
and 8.68% are not very worried. Only 4.74% of the patients are 
not at all worried about the possible shortages. The restrictions 
caused by the pandemic which affected the supply of diabetes 
medication, supplies, and equipment caused the patients to feel 
very worried about possible shortages.  
 
5.3.2. Patients’ Difficulty in Access to Diabetes Medications, 
Food Supplies, and Equipment: 
Table.17. Difficulty in Access to Diabetes Medications, Food 










Not at all 
difficult 





24 6.32% Not very 
difficult 
23 6.05% 
Not easy nor 
difficult 
54 14.21% Not easy nor 
difficult 
25 6.58% 
Difficult 188 49.47% Difficult 185 48.68% 
Very difficult 104 27.37% Very difficult 114 30.00% 
Not applicable 3 0.79% Not applicable 19 5.00% 






f %  
Not at all 
difficult 
11 2.89% 
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Not easy nor 
difficult 
83 21.84% 
Difficult 143 37.63% 
Very difficult 73 19.21% 
Not applicable 4 1.05% 
Total 380 100% 
 
This table shows that 49.47% of the total patients find it 
difficult to access their diabetes medications during the 
COVID-19 pandemic, while 27.37% of the patients find it very 
difficult. In accessing diabetes equipment, 48.68% of the 
patients find it difficult, while 30.00% find it very difficult.  
 
A total of 37.63% of the patients find it difficult to access 
diabetes food supplies, while 21.84% find it neither easy nor 
difficult. Majority of the patients have encountered barriers to 
accessing diabetes medications, supplies, and equipment as 
shown in figure.6, thus, the majority of the patients have 
difficulty in accessing the medications, supplies, and equipment 
that they need.  
5.3.3. Perceived risk of contamination: 









High risk 101 26.58% High risk 84 22.11% 
Low risk 7 1.84% Low risk 28 7.37% 
Moderate risk 29 7.63% Moderate risk 27 7.11% 
No risk 1 0.26% No risk 4 1.05% 
Not applicable 1 0.26% Not applicable 2 0.53% 
Very high risk 241 63.42% Very high risk 235 61.84% 
Total 380 100% Total 380 100% 
 
This table assesses the patients’ level of awareness whether 
they considered themselves at high risk during the COVID-19 
outbreak. It shows that 63.42% of the patients considered 
themselves at very high risk and 26.58% of the patients 
considered themselves at high risk of getting COVID-19. 
Relating to the risk of developing a severe form of COVID-19, 
61.84% of the patients believed the risk to be very high and 
22.11% of the patients believed the risk to be high. Hence, the 
patients were aware that they are at risk of getting COVID-19 
and developing its severe form. 
 
 
5.3.4. Biggest Barriers to Accessing Diabetes Medications, 
Supplies, and Equipment’s 
 
Fig.6. Biggest Barriers to Accessing Diabetes 
Medications/Supplies/Technologies 
 
Figure.6. presents the results of the patients who were asked 
about the top three barriers they encountered accessing diabetes 
medications, supplies, and equipment. A majority of 70.53% of 
the total patients reported that “fear of contamination” as the 
biggest barrier to accessing diabetes medication, supplies and 
equipment.  As stated by Arcellano & Jimeno (2020), diabetic 
patients are high-risk individuals because of their compromised 
innate immunity. Hence, they consider the fear of contracting 
the COVID-19 pandemic as their biggest barrier in accessing 
the medications, supplies, and technologies that they need. The 
next barrier encountered by 59.21% of the patients is supply 
issues or unavailability. In chapter 2, it is stated that the 
lockdown measures imposed in the country caused 
interruptions in the manufacturing and delivery of drugs, 
resulting in unavailability, thus, the majority of the patients 
considered this as a barrier. A total of 56.32% of the patients 
reported that “not being able to leave the house to go and get 
the medication, etc. because I am at high risk” as a barrier to 
their access to medications, supplies, and technologies. 
Diabetic patients are part of the vulnerable population or at 
high-risk of contracting the virus so they are unable to leave the 
house.  
Aside from the top three biggest barriers to accessing diabetes 
medications, supplies, and equipment, 41.84% of the patients 
answered “travel restriction” as a barrier. Due to the community 
quarantine imposed by the IATF, travel restrictions have been 
implemented. 32.11% of the patients considered being unable 
to afford diabetes treatments as a barrier, while 12.37% 
answered “lack of public transportation. The opening time of 
pharmacy is considered by 1.84% of the patients as a barrier, 
while 0.79% of the patients reported being unwell with 
COVID-19 as a barrier. Only 1.58% of the total patients did not 
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have any barriers in accessing diabetes medications, supplies, 
and technologies.  
 
5.3.5. Biggest barriers to accessing diabetes care 
 
Fig.7. Biggest barriers during the COVID-19 pandemic 
The great majority of the patients (96%) had experienced some 
type of barrier in accessing proper diabetic care during the 
pandemic. About 77.63% of the total patients reported that 
“Fear of contamination” was the biggest barrier to their access 
to diabetic care. The next significant barrier among the patients 
would be the travel restrictions, which was reported by 10.63% 
of the total patients. The rest of the barriers are not of great 
significance as they do not represent much of the barriers for 
access to diabetes care. 
 
5.4 Correlation Analysis 
Pearson’s correlation was used to evaluate the relationship 
between the independent variable and the dependent variable. 
The challenges faced by the patients were considered as the 
independent variable while the status on diabetic care was the 
dependent variable. The strength of the relationship of the 
variables is measured by Pearson’s correlation coefficient (r).  
Table.19. Strength of linear relationship 
r value Strength 
At least 0.8 Very strong 
0.6 - 0.8 Moderately strong 
0.3 - 0.5 Fair 
0 - 0.3 Poor 
 
The r value ranges from -1 to 1; in which a value of -1 indicates 
a perfect negative correlation, 1 as a perfect positive 
correlation, and 0 indicates no relationship between the 
variables. The table above shows the strength of the relationship 
corresponding to the value of the correlation coefficient as 
provided by Chan, YH (2003). 
Table.20. Correlation between challenges faced and the status on 
diabetes care 
 Status on 
Diabetes Care 




There is a fair strength relationship between the challenges 
faced by the patients during COVID-19 and their status on 
diabetes care (r=0.41). The analysis supports that the challenges 
faced have a positive correlation to their status on diabetes care. 
This points that both of the variables are related, however the 
strength of that relationship is not that strong. Some patients 
may have a decent status on their diabetes care and 
management, regardless of the challenges they faced. 
Nonetheless, the challenges during the COVID-19 pandemic 
affects the patient’s status on diabetes care. 
The results support the argument that the patients’ status of 
diabetes care and management was affected by their profile and 
challenges they faced during the COVID-19 pandemic. 
Therefore, the null hypothesis should be rejected and the 
alternative hypothesis should be accepted. 
                                      VI.    CONCLUSION 
This chapter brings together the results presented within the 
previous chapter, indicating the summary and the findings, the 
conclusions drawn from the findings and recommendations 
made by the researchers. Moreover, the importance of the study 
is completely stressed out. 
 
 6.1. Summary of Findings 
A descriptive correlational design was used for the 
study, wherein the patients who underwent purposive sampling 
consisted of 380 diabetic patients, aged 18-59 years old, from 
NCR. In order for the researchers to gather data, they used an 
online survey-questionnaire. For the statistical analysis of the 
data gathered, they used frequency and percentage. This study 
was done to determine the challenges faced by patients who 
have diabetes in obtaining quality diabetes care and 
management during the COVID-19 pandemic. It also 
highlighted the status of and challenges on diabetes care and 
management, and their relationship with the patients’ profile. 
The data gathered from the responses of the diabetic patients 
led to significant findings. 
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In terms of their demographic profile, 229 out of 380 or 60.26% 
of the patients were female while 151 out of 380 or 39.74% 
were male. Meanwhile, out of 380 patients, there were 191 or 
50.26% who were employed and working from home, 56 or 
14.74% were employed at their usual place at work, 55 or 
14.47% were self-employed and working from home, 31 or 
8.16% were househusbands/housewives, 23 or 6.05% were 
retired, 11 or 2.89% were unemployed, 7 or 1.84% were 
students, 4 or 1.05% were temporarily not working because of 
COVID-19 but were still employed, and 2 or 0.53% had other 
answers. Moreover, their average monthly income showed that 
131 out of 380 or 34.47% belong to the lower middle income 
class, 117 out of 380 or 30.79% belong to the low-income class 
but were not considered poor, 71 or 18.68% preferred not to 
answer, 44 or 11.58% belong to the middle income class, 9 or 
2.37% belong to the poor income class, 4 or 1.05% belong to 
the upper middle income class, and another 4 or 1.05% belong 
to the upper middle income but were not considered rich. 
With regards to their status on diabetes care and management, 
164 out of 380 or 43.16% said that they have an average ability 
to manage their diabetes during the COVID-19 pandemic. 
Moreover, a significant number of patients consisting of 159 
out of 380 or 41.84% said that they were not effectively 
managing their disease. Furthermore, out of 380 patients, 46 or 
12.11% said that they were effectively managing their diabetes, 
9 or 2.37% said that they were managing their diabetes very 
effectively, and 2 or 0.53% said that they were managing their 
disease not effectively at all. 
When it comes to the challenges faced by patients on diabetes 
care and management, there were 157 out of 380 or 41.32% of 
the patients  who claimed that they find it difficult to follow diet 
restrictions, 86 out of 380 or 22.63% said it was very difficult 
for them, 72 out of 380 or 18.95% stated that it was not easy 
nor difficult for them, 43 out of 380 or 11.32% said it was not 
very difficult for them, 12 out of 380 or 3.16% claimed that it 
was not at all difficult for them, and 10 out of 380 or 2.63% said 
that following diet restrictions was not applicable for them. In 
line with this, 177 out of 380 or 46.58% of the patients stated 
that they find it difficult to follow their food planning methods, 
81 out of 380 or 21.32% find it very difficult, 57 out of 380 or 
15.00% find it neither easy nor difficult, 43 out of 380 or 
11.32% find it not very difficult, 13 out of 380 or 3.42% said 
that following food planning methods was not applicable for 
them, and 9 out of 380 or 2.37% said that following food 
planning methods was not at all difficult for them. 
Furthermore, 188 out of 380 or 49.47% of the patients  declared 
that they find it difficult to access diabetes medication, 104 out 
of 380 or 27.37% of the patients  find it very difficult, 54 out of 
380 or 14.21% of the patients  said it was neither easy nor 
difficult, 24 out of 380 or 6.32% of the patients  find it not very 
difficult, 7 out of 380 or 1.84% of the patients  said it was not 
at all difficult, while 3 out of 380 or 0.79% declared that 
accessing diabetes medication was not applicable for them. 
Meanwhile, 143 out of 380 or 37.63% of the patients said that 
they find it difficult to access diabetes food supplies, 83 out of 
380 or 21.84% of the patients said it was neither easy nor 
difficult, 73 out of 380 or 19.21% find it to be very difficult, 66 
out of 380 or 17.37% find it not very difficult, 11 out of 380 or 
2.89% said it was not all difficult, while 4 out of 380 or 1.05% 
stated that accessing diabetes food supplies was not applicable 
to them. In addition to this, 185 out of 380 or 48.68% of the 
patients claimed that they find it difficult to access diabetes 
equipment, 114 out of 380 or 30.00% of the patients find it very 
difficult, 25 out of 380 or 6.58% said it was neither easy nor 
difficult, 23 out of 380 or 6.05% of the patients said it was not 
very difficult for them, 19 out of 380 or 5.00% of the patients 
stated that accessing diabetes equipment was not applicable to 
them, while 14 out of 380 or 3.68% of the patients said it was 
not at all difficult. 
When the patients were asked about their top three biggest 
barriers to accessing diabetes medication, supplies, and 
technologies during the COVID-19 pandemic, 268 out of 380 
or 70.53% answered fear of contamination, 225 out of 380 or 
59.21% went for supply issues, 214 out of 380 or 56.32% voted 
for not being able to leave, 159 out of 380 or 41.84% said it was 
travel restrictions, 122 out of 380 or 32.11% answered for being 
unable to afford, 47 out of 380 or 12.37% stated that it was the 
lack of public transportation, 7 out of 380 or 1.84% said it was 
the pharmacy opening times, 6 out of 380 or 1.58% declared 
that they faced no barrier to accessing diabetes medication, 
supplies, and technologies, 3 out of 380 or 0.79% claimed that 
it was being unwell with COVID-19, and 3 out of 380 or 0.79% 
said this was not applicable to them. 
 
      5.2. Conclusion 
Based on the findings gathered, the following conclusions 
have been derived.  
 Most of the patients of the study were females. Most of 
the patients were employed, with the majority of those 
working from home. The gross monthly family incomes 
were generally low among the patients as most of them 
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belong to the lower middle income bracket and below. 
This low family income may be attributed to the 
negative effects of the pandemic on businesses as well 
as employment since most establishments and agencies 
use a skeleton workforce as a risk management 
procedure to reduce the chances of infection among 
their employees.  
 An unstable or more variable blood glucose readings 
were seen among most of the patients during the 
pandemic. These unstable readings are indicative of 
poor diabetes management during the COVID-19 
pandemic as it is seen that most of the patients are 
experiencing more hyperglycemic events compared 
prior to the pandemic. Moreover, the patients described 
their status of diabetes care and management during the 
COVID-19 pandemic as not effective. This poor rating 
may be attributed to the challenges faced by these 
patients. 
 The data gathered presented that the biggest challenges 
faced by the patients are fear of contamination, supply 
issues, and not being able to leave because of high risk. 
As a result of these three, they also find it difficult to 
access their diabetes medicines and equipment, as well 
as their diabetes food supplies as most of them had 
experienced difficulties in following their strict diet and 
food planning methods.  
 Based on these findings, the study failed to accept the 
null hypothesis that the patients’ status of diabetes care 
and management was not affected by their profile and 
challenges they faced during the COVID-19 pandemic. 
There was evidence to suggest that the patient’s social 
status and the challenges they faced during the 




After the study has gone through refinement and apprehension, 
the researchers came up with these highly significant 
recommendations. 
 For Future Researchers. The study mainly focused on 
diabetes care and management in NCR during the 
COVID-19 pandemic. Thus, it is recommended that 
future studies will look into diabetes care and 
management in other regions of the country. Future 
researchers could apply a comparison and contrast 
method in their investigations, comparing the data 
gathered from this study to data collected in another 
setting to point out the similarities and differences in 
diabetes care and management among different regions 
during the COVID-19 pandemic. Meanwhile, due to the 
COVID restrictions raised by IATF, the researchers 
were not able to directly collaborate with authorities 
and purely relied on secondary data with respect to the 
total population of diabetic patients in NCR. Therefore, 
future researchers are recommended to collaborate with 
authorities such as certain health institutions, 
Nongovernment Organizations (NGOs) and Local 
Government Units for more accurate and up-to-date 
data.  
 For the Government and Healthcare Providers. Based 
on the challenges faced by the patients and their status 
of diabetes care and management, the researchers 
highly recommend the government to focus on 
innovation, virtualization, and digitalization of 
healthcare systems in the country. This shall be done in 
a way that is more accessible to the general public 
considering the limitations of the patients during the 
pandemic. This will help the patients continue the 
monitoring of their disease with a health professional 
even at the comfort of their home. Moreover, healthcare 
providers can show up in television or radio 
advertisements or even in social media platforms to 
raise awareness on the possible changes in healthcare 
delivery in the country. This will help reach more 
people who need medical assistance and, in turn, will 
improve the care and management of the disease. 
 For Diabetic Patients and the General Public. Reducing 
the incidence of diabetes must be one of the focuses of 
both the national health department and local health 
units to improve the health of the general population. 
Achieving this results in fewer comorbidities and helps 
ease burden on hospitals in terms of manpower and 
expenditures in the case of another pandemic.  This may 
be achieved through interventions such as educating 
and bringing awareness to the general public about 
diabetes and its complications, initiating policies and 
programs that promote living a healthy lifestyle, and 
providing accessible screening for pre-diabetic 
patients. Those already with diabetes must be mindful 
of their lifestyle choices to better manage their disease, 
as well as reduce their chances of developing 
complications. They should be well aware of their 
needs by constantly monitoring their condition and 
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making trips to their health center for general 
examination to improve their health outcome. 
 There was evidence to suggest that the patient’s social 
status and the challenges they faced during the 
pandemic, have an effect on their diabetes care and 
management. Most of the patients of the study were 
females. Most were employed, with the majority of 
those working from home. The gross monthly family 
incomes were generally low among the patients as most 
of them belong to the lower middle income bracket and 
below. This low family income may be attributed to the 
negative effects of the pandemic on businesses as well 
as employment since most establishments and agencies 
use a skeleton workforce as a risk management 
procedure to reduce the chances of infection among 
their employees. An unstable or more variable blood 
glucose readings were seen among most of the patients 
during the pandemic. These unstable readings are 
indicative of poor diabetes management during the 
COVID-19 pandemic as it is seen that most of the 
patients are experiencing more hyperglycemic events 
compared prior to the pandemic. The biggest challenges 
faced by the patients are fear of contamination, supply 
issues, and not being able to leave because of high risk. 
As a result of these three, they also find it difficult to 
access their diabetes medicines and equipment, as well 
as their diabetes food supplies as most of them had 
experienced difficulties in following their strict diet and 
food planning methods. 
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